ClinicalTrials.Veeva

Menu

Exploration of Neuroimaging and Biochemical Prognostic Indicators for POCD

W

wangqiang

Status

Unknown

Conditions

Cognitive Impairment
Postoperative Cognitive Dysfunction

Study type

Observational

Funder types

Other

Identifiers

NCT02164669
20130225-8

Details and patient eligibility

About

Postoperative cognitive dysfunction (POCD) may lead to serious consequences. But the underlying mechanisms are still unclear. Blood Oxygen Level Dependent (BOLD) fMRI and biochemical indicators will be used to explore the underlying mechanisms and represent a promising precursory target for diagnosis and treatment of POCD.

Full description

Postoperative cognitive dysfunction (POCD) is one of the most common complications in patients undergoing cardiac surgery. POCD will not only increase the incidence of complications and mortality, but also influence the quality of life after discharging from the hospital. Many factors are associated with POCD, such as neuroinflammation, age, anesthetics, surgery stress response and genetic factors. But the underlying mechanisms are still unclear. Blood Oxygen Level Dependent (BOLD) fMRI, which could monitor the peripheral neuron spontaneous activity according to the ratio of oxyhemoglobin and deaeration hemoglobin in blood, will be used to investigate whether POCD is induced by the variance in neurons metabolism and spontaneous activity in brain regions. Meanwhile, biochemical indicators will be detected to explore the prompting indicators of POCD. The present study is aimed to represent a promising precursory target for diagnosis and treatment of POCD, and provide novel evidence and insights on the brain changes induced by POCD.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 18-80 years old
  • Underwent selective CABG surgery

Exclusion criteria

  • History of central nervous system or psychiatric disorders
  • History of taking sedative, antidepressants, or alcoholism
  • MMSE score less than 23
  • Visual or auditory disorders
  • Educated less than 7 years
  • Claustrophobia
  • Can not be supine
  • Can not tolerate iodinated contrast agents

Trial contacts and locations

1

Loading...

Central trial contact

Qiang Wang, MD,PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems